Janet Rose Rea
Direttore operativo presso Ave Maria Biotechnology LLC
Profilo
Janet Rose Rea is currently the Chief Operating Officer at Ave Maria Biotechnology LLC.
Previously, she worked as the VP-Regulatory Affairs, Quality & Clinical Affairs at Atossa Therapeutics, Inc. from 2015 to 2020.
She also served as an Assistant Clinical Professor at the University of Washington.
Ms. Rea completed her undergraduate and graduate degrees at the University of Washington.
Posizioni attive di Janet Rose Rea
Società | Posizione | Inizio |
---|---|---|
Ave Maria Biotechnology LLC
Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Direttore operativo | 08/07/2020 |
Precedenti posizioni note di Janet Rose Rea
Società | Posizione | Fine |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Consigliere Generale | 01/07/2020 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formazione di Janet Rose Rea
University of Washington | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ATOSSA THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Ave Maria Biotechnology LLC
Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Commercial Services |
- Borsa valori
- Insiders
- Janet Rose Rea